Tag Archives: EV manufacturing

Exosomes Europe 2026 will highlight advances in extracellular vesicles engineering, manufacturing, analytics, potency testing, clinical translation and regulatory strategies for therapeutic development...

Scalable manufacturing of extracellular vesicles aims to reduce cost, improve consistency, and accelerate development of EV-based therapeutics for broader...

Extracellular vesicles, particularly exosomes, are redefining drug delivery and regenerative medicine by offering scalable, targeted therapeutic solutions. With insights from industry pioneers, the 2025 agenda highlights breakthroughs in manufacturing...